Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

NCT00004067 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2130

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: herceptin
DRUG: adriamycin
DRUG: cyclophosphamide
DRUG: taxol

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]